Global Congestive Heart Failure Market, [by Product (Counter Pulsation Devices, Implantable Cardioverter Defibrillations (Transveneuous ICD, Subcutaneous ICD), Ventricular Assisted Device (Left Ventricular Assist Device, Right Ventricular Assist Device, and Biventricular Assist Device), Pacemakers (External Pacemakers, Internal Pacemakers), Cardiac Resynchronization Therapy (Cardiac Resynchronization Therapy-Pacemakers, Cardiac Resynchronization Therapy-Defibrillations)), by End Users (Cardio Vascular Disease Treatment Centres, Ambulatory Surgical Centres, Hospitals)]; and Geography - Trend, Analysis and Forecast till 2025
Report Summary
The Global Congestive Heart Failure Market Size is anticipated to gain traction in future due to the increasing number of patients suffering from heart related disorders, and increasing surgical intervention in treating theses disorders.
Congestive heart failure is termed as a condition in which the blood pumped by heart is unable to meet the body needs. Congestive heart failure leads to heart attacks or heart failures. Congestive heart failures are of two types namely left sided heart failure and right sided failure, left sided CHF is commonly noted type of CHF. Congestive heart failure is primarily caused due to hypertension, coronary artery disease, and other conditions. CHF is characterised by symptoms such as poor feeding, excessive sweating, and difficulty in breathing. CHF can be diagnosed by tests like electrocardiogram, blood test, stress test, and cardiac catheterization. There are various treatment drugs available in the market which includes ACE inhibitors, beta-blockers, Diuretics, and surgeries.
Congestive heart failure is being projected to increase dramatically due to rising number of cardiovascular diseases that are majorly caused due to changing lifestyle of the population globally, and changing diet preferences by the individuals.
Technological advancements and increasing surgical interventions as novel treatment therapies to boost the congestive heart failure market.
The congestive heart failure market is primarily driven by the increasing adoption of western diets due to changed life style of individuals globally. Fast track approvals of for innovative drugs and devices that help in proper diagnosis and treatment of congestive heart failure, and increasing need for treating the CHF in the developing market would also influence the growth. While, increasing number of patients suffering from the cardiovascular diseases is the major factor that is increasing the revenue of congestive heart failure market. According to WHO, 17.7 million people died in 2015 due to cardiovascular diseases that represented approximately 31% of global deaths.
However, higher cost of the available treatments and devices, and unmet regulatory policies are the factors that would hinder the growth of congestive heart failure market during the forecast period.
Global congestive heart failure Market Taxonomy
The congestive heart failure market is segmented on the basis of products, end use and geography.
On the basis of products, the global cancer pain management market is segmented as:
- Counter Pulsation Devices
- Implantable Cardioverter Defibrillations
- Transveneuous ICD
- Subcutaneous ICD
- Ventricular Assisted Device
- Left Ventricular Assist Device (LVAD)
- Right Ventricular Assist Device (RVAD)
- Biventricular Assist Device (BVAD)
- Pacemaker
- External Pacemakers
- Internal Pacemakers
- Cardiac Resynchronization Therapy
- Cardiac Resynchronisation Therapy –Pacemakers
- Cardiac Resynchronisation Therapy –Defibrillations
On the basis of end use, the global cancer pain management market is segmented as:
- Cardiovascular Diseases Treatment Centre
- Ambulatory Surgical Centre
- Hospitals
Geographically, the congestive heart failure market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
On the basis of geography, North America is expected to dominate the global congestive heart failure market size over forecast period. The congestive heart failure market is primarily driven by rising number of aging population in this region, and increasing research & development for new diagnostics and innovation of novel treatments for cardiovascular diseases by the manufacturers. Moreover, increased awareness would spur the market of congestive heart failure in North America
However, Asia Pacific market is expected to witness lucrative growth in this market owning to the increasing number of aging population, and untapped market potential in the developing countries.
Key players in the global congestive heart failure market are:
- ReliantHeart, Inc.
- Jarvik Heart Inc.
- Biotronik SE & Co., KG
- Jude Medical, Inc.
- Berlin Heart GmbH
- Medtronic plc.
- Teleflex Inc.
- Boston Scientific Corporation
- MicroMed Cardiovascular Inc.
- Thoratec
- LivaNova Inc.
- AbioMed
